STAT

Documentarian Alex Gibney has taken on Enron, Scientology — and now Theranos

Documentarian Alex Gibney's latest subject — after Enron executives, cyclist Lance Armstrong, and a Scientology leader — is Elizabeth Holmes of Theranos.
Source: Kristoffer Tripplaar/AP

For more news about West Coast life sciences, health care, and biotech, sign up to receive “Go West,” STAT’s weekly newsletter.

SAN FRANCISCO — In Alex Gibney’s career as a documentarian, he’s spent a lot of time peering into ingenious fraudsters, liars, and questionable charismatic figures. Among them: the Enron executives, the cyclist Lance Armstrong, and Scientology leader David Miscavige.

Which is why it comes as no surprise that his latest subject is Elizabeth Holmes.

Gibney’s Theranos documentary, “The Inventor,” will be in theaters for one week starting on Friday in San Francisco, Los Angeles, and New York City. It will premiere on HBO on Monday night. STAT sat down with Gibney to talk about his new film at a premiere on Monday night here in the lion’s den.

In your view, how does Elizabeth Holmes compare to some of these other figures you’ve made films about? In what ways does she stand out — and where do you

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readSociety
Opinion: Eliminating ‘Tensions’ In Health Care: A Litmus Test For Innovation
The challenge in applying the term innovation in health care is that the relationship between the "buyer" (patient) and the "seller" (provider) is convoluted by many other players.
STAT3 min readSociety
Opinion: Dreamers Like Me Fill Critical Gaps In Mental Health Care. The Dream And Promise Act Will Let Us Keep Doing That
Passing the American Dream and Promise Act to give Dreamers a pathway to citizenship would benefit not just the Dreamers but also the health care system and all of the…
STAT8 min readSociety
Mental Health Apps Are Scooping Up Your Most Sensitive Data. Will You Benefit?
Mental health apps can put patients’ privacy at risk, and makers of some tools are using the data collected to create products that have nothing to do with health care.